New Zealand markets close in 2 hours

Dr. Reddy's Laboratories Limited (RDY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
69.30-0.35 (-0.50%)
At close: 04:00PM EDT
69.57 +0.27 (+0.39%)
After hours: 05:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.71B
Enterprise value 10.94B
Trailing P/E 17.38
Forward P/E 20.20
PEG ratio (5-yr expected) 3.51
Price/sales (ttm)3.47
Price/book (mrq)3.43
Enterprise value/revenue 3.27
Enterprise value/EBITDA 10.34

Trading information

Stock price history

Beta (5Y monthly) 0.34
52-week change 329.56%
S&P500 52-week change 326.36%
52-week high 377.72
52-week low 353.13
50-day moving average 372.99
200-day moving average 370.14

Share statistics

Avg vol (3-month) 3199.88k
Avg vol (10-day) 3289.28k
Shares outstanding 5166.53M
Implied shares outstanding 6168.27M
Float 8119.75M
% held by insiders 10.00%
% held by institutions 114.99%
Shares short (30 Apr 2024) 4751k
Short ratio (30 Apr 2024) 44.71
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.52%
Shares short (prior month 28 Mar 2024) 4625.76k

Dividends & splits

Forward annual dividend rate 40.49
Forward annual dividend yield 40.70%
Trailing annual dividend rate 340.00
Trailing annual dividend yield 357.43%
5-year average dividend yield 40.72
Payout ratio 411.96%
Dividend date 311 Aug 2023
Ex-dividend date 407 Jul 2023
Last split factor 22:1
Last split date 307 Sept 2006

Financial highlights

Currency in INR.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.95%
Operating margin (ttm)20.87%

Management effectiveness

Return on assets (ttm)11.67%
Return on equity (ttm)21.77%

Income statement

Revenue (ttm)279.16B
Revenue per share (ttm)280.18
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)N/A
EBITDA 81.05B
Net income avi to common (ttm)55.68B
Diluted EPS (ttm)4.01
Quarterly earnings growth (yoy)36.30%

Balance sheet

Total cash (mrq)81.47B
Total cash per share (mrq)489.26
Total debt (mrq)20.02B
Total debt/equity (mrq)7.14%
Current ratio (mrq)2.58
Book value per share (mrq)1,684.80

Cash flow statement

Operating cash flow (ttm)45.43B
Levered free cash flow (ttm)15.07B